Delek Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$20.1M Hold
210,544
0.78% 50
2019
Q1
$21.1M Buy
210,544
+20,000
+10% +$1.78M 0.88% 38
2018
Q4
$16M Buy
190,544
+20,000
+12% +$1.82M 0.73% 47
2018
Q3
$16.7M Buy
170,544
+102,168
+149% +$10.8M 0.7% 46
2018
Q2
$7.41M Hold
68,376
0.32% 107
2018
Q1
$7.13M Sell
68,376
-1,475
-2% -$172K 0.37% 102
2017
Q4
$8.2M Buy
+69,851
New +$7.23M 0.44% 83

Other funds holding CRI

Delek Group's CRI Position: Q2 2019 in Review

Delek Group held its Carter's (CRI) position steady in Q2 2019 at 210,544 shares worth $20.1M. The position accounts for 0.78% of the portfolio, ranked #50.

Delek Group first reported a position in CRI in Q4 2017 and has held it in 7 quarters since. The position peaked at $21.1M in Q1 2019. 305 funds tracked by Wall St. Rank hold CRI as of Q2 2019.

  • Delek Group held 210,544 shares of Carter's worth $20.1M as of Q2 2019.
  • Delek Group left its Carter's share count unchanged in Q2 2019.
  • Carter's made up 0.78% of Delek Group's portfolio in Q2 2019, its #50 holding.
  • Delek Group first reported a position in Carter's in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Carter's position peaked at $21.1M in Q1 2019.
  • 305 funds tracked by Wall St. Rank held Carter's as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.